Nanomedicine and Nanoscale Delivery (NND)

Nanomedicine and Nanoscale Delivery (NND)

The use of nanosystems has opened multiple new doors in the field of drug delivery, and has become an extremely popular research focus area throughout the world. A number of exciting advancements in the field have already improved the therapeutic potential of old and new drugs. Still, the massive potential of nanomedicines is not yet within our grasp and efforts in the field are largely exploratory. The Nanomedicine and Nano-Scale Delivery Focus Group will serve investigators from universities and research institutes with scientific interests on the development of nanomedicines for drug delivery applications, industrial researchers from companies with R&D in nanosystems and experts from regulatory boards, all under the umbrella of CRS. Our vision is to foster an integrative and progressive discussion forum for all those engaged in the wide field of nanomedicine and biomedical nanotechnology.

The members of the Focus Group are expected to be paid members of the Controlled Release Society, independent of their membership category.

Access the Member-Only Community

Newsletters

Featured Articles

Webinars

STAY CONNECTED.

   

Leadership:

Chair
Maria de la Fuente
Scientific Researcher - FUNDACION IDIS-SERGAS
Vice-Chair
Helena Florindo
Assistant Professor - University of Lisbon
Secretary
Christian Celia
Industry Representative
Luis Santos
Industry Representative
Matthew O'Brien
Academic Representative
Assaf Zinger
Academic Representative
Eun Ji Chung
Trainee
Orlagh Feeney
Communications
Marwa Sallam
Communications
Laura Taina
Focus Group Advisor
Ruth Schmid